Manufacturers should exhibit that any new technology or approach not just satisfies the prevailing expectations for sterility assurance but in addition offers tangible Gains in terms of effectiveness, dependability, or solution safety. As these new technologies arise, the WHO emphasizes the value of an intensive hazard assessment and validat